B
Balaxi Pharmaceuticals
BALAXI Share Price
Healthcare27.50
NSE
as on 23 Apr 2026 at 15:28
Market Cap
₹152 Cr
PE Ratio
16.10
ROCE
12.35%
BALAXI Fundamentals
Company Valuation
Market Cap (₹ Cr.)
152
PE Ratio
16.10
PB Ratio
0.64
Dividend Yield
1.82%
ROE
10.82%
ROCE
12.35%
Book Value (₹)
43.12
Face Value (₹)
2.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 65.99% | 65.99% | 65.99% | 65.99% | 65.99% |
| Domestic Institutional Investors (DII) | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 1.74% |
| Public Investors | 9.69% | 9.82% | 16.14% | 20.03% | 22.39% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
BALAXI Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
0
NSE Scrip Name
BALAXI
ISIN
INE618N01022



